How much funding has Vascular Biogenics raised?

Vascular Biogenics has raised $30.9M in total funding, most recently a grant round.

When was Vascular Biogenics founded?

Vascular Biogenics was founded in 2000.

Where is Vascular Biogenics headquartered?

Vascular Biogenics is headquartered in Yehud, Israel.

What industry is Vascular Biogenics in?

Vascular Biogenics operates in Biotech, Healthcare.

How many employees does Vascular Biogenics have?

Vascular Biogenics has 51-200 employees.

Vascular Biogenics

Q: Who are Vascular Biogenics's investors?

Vascular Biogenics's investors include European Innovation Council Fund, ROTH Capital Partners.

Acquired

Public · Yehud, Israel · Founded 2000 · $30.9M raised

Biotech

Healthcare

Headquarters: Yehud
Employees: 51–200
Founded: 2000
Business Model: B2B
Website: vblrx.com

Total Funding: $30.9M
Last Round: $2.5M GrantOct 2021
Rounds: 2
Type: Public

About

Israeli clinical-stage biopharmaceutical company developing targeted gene therapies and small molecule drugs for immune-inflammatory diseases; trades on Nasdaq as VBLT.

Summary

Vascular Biogenics is a Biotech company based in Yehud, Israel, founded in 2000. It has raised $30.9M in total across 2 rounds, most recently a $2.5M Grant round in Oct 2021. Investors include European Innovation Council Fund and ROTH Capital Partners.